Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Takeda Pharmaceutical Company Limited”

1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,022
Index total 30,257
Page 38 / 43

Quick answer

This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,022 results for “Takeda Pharmaceutical Company Limited” · 30,257 patents in full index Clear search

  1. US 7553867

    Furan or thiophene derivative and medicinal use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted
  2. US 7550598

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted
  3. US 7550590

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted
  4. US 7541478

    Coumarin derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 2, 2009 · Expires May 28, 2029

    granted
  5. US 7538125

    Pharmaceutical composition

    Takeda Pharmaceutical Company Limited · Granted May 26, 2009 · Expires May 21, 2029

    granted
  6. US 7538133

    Benzimidazole derivatives, their production and use

    Takeda Pharmaceutical Company Limited · Granted May 26, 2009 · Expires May 21, 2029

    granted
  7. US 7534887

    Thiazoline derivative and use of the same

    Takeda Pharmaceutical Company Limited · Granted May 19, 2009 · Expires May 14, 2029

    granted
  8. US 7521545

    Azo compounds and process for production thereof

    Takeda Pharmaceutical Company Limited · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted
  9. US 7517910

    Alkoxyphenylpropanoic acid derivatives

    Takeda Pharmaceutical Company Limited · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted
  10. US 7517661

    Methods of screening for ligands for FPRL2

    Takeda Pharmaceutical Company Limited · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted
  11. US 7514441

    Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents

    Takeda Pharmaceutical Company Limited · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted
  12. US 7510728

    Solid preparations

    Takeda Pharmaceutical Company Limited · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted
  13. US 7507740

    Fused heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  14. US 7507841

    Cannabinoid receptor modulator

    Takeda Pharmaceutical Company Limited · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  15. US 7498352

    TGF-β superfamily production/secretion promoter

    Takeda Pharmaceutical Company Limited · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted
  16. US 7498337

    Acid secretion inhibitor

    Takeda Pharmaceutical Company Limited · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted
  17. US 7495018

    Substituted 1,3-thiazole compounds, their production and use

    Takeda Pharmaceutical Company Limited · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  18. US 7491802

    Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer

    Takeda Pharmaceutical Company Limited · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted
  19. US 7479484

    Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity

    Takeda Pharmaceutical Company Limited · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted
  20. US 7476657

    Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments

    Takeda Pharmaceutical Company Limited · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted
  21. US 7470700

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted
  22. US 7465815

    Cannabinoid receptor modulator

    Takeda Pharmaceutical Company Limited · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted
  23. US 7462628

    Preventives/remedies for urinary disturbance

    Takeda Pharmaceutical Company Limited · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted
  24. US 7462635

    Thiazole and oxazole VDAC regulator

    Takeda Pharmaceutical Company Limited · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted